SELAS FARMALOR : revenue, balance sheet and financial ratios

SELAS FARMALOR is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BOIS-GUILLAUME (76230), this company of category PME shows in 2024 a revenue of 3.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS FARMALOR (SIREN 793373291)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C 3 546 696 € 3 434 625 € 3 335 472 € 2 763 727 € 2 402 534 € 2 111 532 € 2 049 759 € N/C
Net income 128 458 € -66 206 € 190 897 € 358 119 € 152 558 € 62 329 € 113 270 € 115 460 € 145 310 €
EBITDA N/C 13 689 € 289 345 € 522 767 € 258 354 € 114 470 € 173 947 € 174 098 € N/C
Net margin N/C -1.9% 5.6% 10.7% 5.5% 2.6% 5.4% 5.6% N/C

Revenue and income statement

In 2025, SELAS FARMALOR generates positive net income of 128 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 145 k€ -> 128 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

128 458 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 116%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

116.401%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

35.391%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

42.5%

Solvency indicators evolution
SELAS FARMALOR

Sector positioning

Debt ratio
116.4 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average +24 pts over 3 years

In 2025, the debt ratio of SELAS FARMALOR (116.40) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
35.39% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average -23 pts over 3 years

In 2025, the financial autonomy of SELAS FARMALOR (35.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
175.95 years 2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Watch +41 pts over 2 years

In 2024, the repayment capacity of SELAS FARMALOR (175.95) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 153.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

153.911

Liquidity indicators evolution
SELAS FARMALOR

Sector positioning

Liquidity ratio
153.91 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average -21 pts over 3 years

In 2025, the liquidity ratio of SELAS FARMALOR (153.91) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
69.74x 2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Excellent +38 pts over 2 years

In 2024, the interest coverage of SELAS FARMALOR (69.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS FARMALOR

Positioning of SELAS FARMALOR in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELAS FARMALOR is estimated at 2 040 570 € (range 1 384 740€ - 3 201 936€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1384k€ 2040k€ 3201k€
2 040 570 € Range: 1 384 740€ - 3 201 936€
NAF 5 année 2025

Valuation method used

Net Income Multiple
128 458 € × 15.9x = 2 040 571 €
Range: 1 384 741€ - 3 201 936€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS FARMALOR with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS FARMALOR

What is the revenue of SELAS FARMALOR ?

The revenue of SELAS FARMALOR in 2024 is 3.5 M€.

Is SELAS FARMALOR profitable?

Yes, SELAS FARMALOR generated a net profit of 128 k€ in 2025.

Where is the headquarters of SELAS FARMALOR ?

The headquarters of SELAS FARMALOR is located in BOIS-GUILLAUME (76230), in the department Seine-Maritime.

Where to find the tax return of SELAS FARMALOR ?

The tax return of SELAS FARMALOR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS FARMALOR operate?

SELAS FARMALOR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.